METRION PHARMA LTD

Active Cambridge

Other research and experimental development on natural sciences and engineering

0 employees website.com
Other research and experimental development on natural sciences and engineering
M

METRION PHARMA LTD

Other research and experimental development on natural sciences and engineering

Founded 14 Feb 2018 Active Cambridge, United Kingdom 0 employees website.com
Other research and experimental development on natural sciences and engineering
Accounts Submitted 17 Jun 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 12 Feb 2026 Next due 26 Feb 2027 8 months remaining
Net assets £-404 £110 2024 year on year
Total assets £146 £40 2024 year on year
Total Liabilities £550 £150 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

First Floor, Building 2 Granta Centre, Granta Park Great Abington Cambridge CB21 6AL United Kingdom

Full company profile for METRION PHARMA LTD (11206419), an active company based in Cambridge, United Kingdom. Incorporated 14 Feb 2018. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type dormant
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£46.00

Increased by £40.00 (+667%)

Net Assets

-£404.00

Decreased by £110.00 (-37%)

Total Liabilities

£550.00

Increased by £150.00 (+38%)

Turnover

N/A

Employees

N/A

Debt Ratio

377%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Clare Louise RuttySecretaryUnknownUnknown11 Jun 2019Active

Shareholders

Shareholders (1)

Metrion Biosciences Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 14 Feb 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

METRION PHARMA LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Feb 2026Confirmation StatementConfirmation statement made on 12 Feb 2026 with updates
17 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
24 Feb 2025OfficersTermination of Andrew Phillip Lightfoot as director on 21 Feb 2025
13 Feb 2025Confirmation StatementConfirmation statement made on 13 Feb 2025 with no updates
10 Dec 2024OfficersTermination of Andrew Paul Southan as director on 30 Nov 2024
12 Feb 2026 Confirmation Statement

Confirmation statement made on 12 Feb 2026 with updates

17 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

24 Feb 2025 Officers

Termination of Andrew Phillip Lightfoot as director on 21 Feb 2025

13 Feb 2025 Confirmation Statement

Confirmation statement made on 13 Feb 2025 with no updates

10 Dec 2024 Officers

Termination of Andrew Paul Southan as director on 30 Nov 2024

Recent Activity

Latest Activity

Confirmation statement made on 12 Feb 2026 with updates

3 months ago on 12 Feb 2026

Annual accounts made up to 31 Dec 2024

11 months ago on 17 Jun 2025

Termination of Andrew Phillip Lightfoot as director on 21 Feb 2025

1 years ago on 24 Feb 2025

Confirmation statement made on 13 Feb 2025 with no updates

1 years ago on 13 Feb 2025

Termination of Andrew Paul Southan as director on 30 Nov 2024

1 years ago on 10 Dec 2024